Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy

COMBINED INTRAVITREAL BEVACIZUMAB INJECTION AND ZONE I SPARING LASER PHOTOCOAGULATION IN PATIENTS WITH ZONE I RETINOPATHY OF PREMATURITY

(2013) Jaeryung Kim et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Vascular Endothelial Growth Factor A Competitively Inhibits Platelet-Derived Growth Factor (PDGF)-Dependent Activation of PDGF Receptor and Subsequent Signaling Events and Cellular Responses

(2012) S. Pennock et al.   MOLECULAR AND CELLULAR BIOLOGY

Current Role of Cryotherapy in Retinopathy of Prematurity

(2012) Jennifer L. Simpson et al.   OPHTHALMOLOGY

Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy

(2011) D. K. Packham et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion

(2011) A. Pletinck et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Inhibition of Reactive Gliosis Prevents Neovascular Growth in the Mouse Model of Oxygen-Induced Retinopathy

(2011) Michael DeNiro et al.   PLoS One

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus

(2010) L. N. Broekhuizen et al.   DIABETOLOGIA

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

(2009) Kip M Connor et al.   Nature Protocols